112 related articles for article (PubMed ID: 24417061)
1. [The problem of growing resistance of microorganisms to antibiotic therapy and prospects for Helicobacter pylori eradication].
Tsimmerman IaS
Klin Med (Mosk); 2013; 91(6):14-20. PubMed ID: 24417061
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutics of infection by Helicobacter pylori in 2008].
Corti R; Doweck J; Schenone L; Améndola R; Giordano Romano A
Rev Gastroenterol Mex; 2008; 73(2):93-105. PubMed ID: 19666254
[TBL] [Abstract][Full Text] [Related]
3. Eradication therapy for Helicobacter pylori.
Vakil N; Megraud F
Gastroenterology; 2007 Sep; 133(3):985-1001. PubMed ID: 17854602
[TBL] [Abstract][Full Text] [Related]
4. Moxifloxacin-containing triple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate.
Yoon H; Kim N; Lee BH; Hwang TJ; Lee DH; Park YS; Nam RH; Jung HC; Song IS
Helicobacter; 2009 Oct; 14(5):77-85. PubMed ID: 19751431
[TBL] [Abstract][Full Text] [Related]
5. [Failure in the eradication of Helicobacter pylori: the role of antibiotic resistance].
Lengyel G; Zsolt T
Orv Hetil; 2005 May; 146(18):839-42. PubMed ID: 15926629
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Helicobacter pylori infection in the aspect of increasing antibiotic resistance.
Iwańczak F; Iwańczak B
Adv Clin Exp Med; 2012; 21(5):671-80. PubMed ID: 23356205
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Helicobacter pylori.
Bytzer P; O'Morain C
Helicobacter; 2005; 10 Suppl 1():40-6. PubMed ID: 16178970
[TBL] [Abstract][Full Text] [Related]
8. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
[TBL] [Abstract][Full Text] [Related]
9. [Helicobacter pylori: what schemes of eradication are essential today?].
Maev IV; Samsonov AA; Golubev NN
Ter Arkh; 2011; 83(8):41-4. PubMed ID: 21961331
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Helicobacter pylori infection.
O'Connor A; Gisbert J; O'Morain C
Helicobacter; 2009 Sep; 14 Suppl 1():46-51. PubMed ID: 19712168
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori.
Fischbach L; Evans EL
Aliment Pharmacol Ther; 2007 Aug; 26(3):343-57. PubMed ID: 17635369
[TBL] [Abstract][Full Text] [Related]
12. [Microbial antagonism and rationale for the use of probiotics in combined therapy of Helicobacter pylori-related diseases].
Tsimmerman IaS; Subbotina LV; Neschisliaev VA
Klin Med (Mosk); 2010; 88(4):35-42. PubMed ID: 20919568
[TBL] [Abstract][Full Text] [Related]
13. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
[TBL] [Abstract][Full Text] [Related]
14. [Alternative schemes of eradication therapy and ways of overcoming acquired resistance of Helicobacter pylori to the treatment].
Tsimmerman IaS
Klin Med (Mosk); 2004; 82(2):9-15. PubMed ID: 15106503
[TBL] [Abstract][Full Text] [Related]
15. Bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate in Korea.
Lee BH; Kim N; Hwang TJ; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS
Helicobacter; 2010 Feb; 15(1):38-45. PubMed ID: 20302588
[TBL] [Abstract][Full Text] [Related]
16. Eradication of Helicobacter pylori in children in Vietnam in relation to antibiotic resistance.
Nguyen TV; Bengtsson C; Yin L; Nguyen GK; Hoang TT; Phung DC; Sörberg M; Granström M
Helicobacter; 2012 Aug; 17(4):319-25. PubMed ID: 22759333
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of antimicrobial susceptibility in the eradication of Helicobacter pylori.
Cosme A; Montes M; Martos M; Gil I; Mendarte U; Salicio Y; Piñeiro L; Recasens MT; Ibarra B; Sarasqueta C; Bujanda L
Clin Microbiol Infect; 2013 Apr; 19(4):379-83. PubMed ID: 22512623
[TBL] [Abstract][Full Text] [Related]
18. [The evoluation of the strategy and tactics of treatment of Helicobacter pylori-dependent diseases].
Tsimmerman IaS
Klin Med (Mosk); 2007; 85(8):9-14. PubMed ID: 17926482
[TBL] [Abstract][Full Text] [Related]
19. Resistance mechanisms of Helicobacter pylori and its dual target precise therapy.
Gong Y; Yuan Y
Crit Rev Microbiol; 2018 May; 44(3):371-392. PubMed ID: 29293032
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Helicobacter pylori.
Egan BJ; Katicic M; O'Connor HJ; O'Morain CA
Helicobacter; 2007 Oct; 12 Suppl 1():31-7. PubMed ID: 17727458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
